Review, reevaluation, and new results in quantitative structure‐activity studies of anticonvulsants

This paper reviews and reevaluates all of the published QSAR treatments of anticonvulsants and extends them to a new relationship. This reveals that in almost all cases, the Clog P relationship plays a significant part in the QSAR relationship whether the data stems from receptor to whole animal studies. In some cases the steric factors (B5, B1, and L) are important and, in one case, the log VW relationship is of marginal importance. Electronic effects, except for the Hammett's constant σ, are comparatively unimportant. This suggests that the receptors involved possess a special stereochemical and electronic feature: The aromatic ring and the nitrogen moieties (e.g., an amide group) are the primary binding groups. The study shows that log P, as calculated by the Clog P program, is suitable for this form of QSAR study. Log Po of 2 was found to be ideal for passive penetration of these agents into the CNS. © 1998 John Wiley & Sons, Inc., Med Res Rev, 18, No. 2, 91–119, 1998.

[1]  J. Quail,et al.  (Aryloxy)aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen. , 1996, Journal of medicinal chemistry.

[2]  A. Leo,et al.  Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. , 1987, Journal of pharmaceutical sciences.

[3]  J. Ferrendelli,et al.  Synthesis and structure-activity studies of alkyl-substituted gamma-butyrolactones and gamma-thiobutyrolactones: ligands for the picrotoxin receptor. , 1991, Journal of medicinal chemistry.

[4]  T. Latifi,et al.  Synthesis and Anticonvulsant Activities of 3,3-Dialkyl- and 3-Alkyl-3-benzyl-2-piperidinones (δ-Valerolactams) and Hexahydro-2H-azepin-2-ones (ε-Caprolactams) , 1997 .

[5]  Albert J. Leo,et al.  [25] Hydrophobic parameter: Measurement and calculation , 1991 .

[6]  D. Hirschfeld,et al.  1-(Naphthylalkyl)-1H-imidazole derivatives, a new class of anticonvulsant agents. , 1981, Journal of medicinal chemistry.

[7]  A. Leo CALCULATING LOG POCT FROM STRUCTURES , 1993 .

[8]  T. Lynes,et al.  THE ANTICONVULSANT PROPERTIES OF SOME SUBSTITUTED BENZAMIDES. , 1963, Journal of medicinal chemistry.

[9]  A M Triggle,et al.  1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach. , 1988, Journal of medicinal chemistry.

[10]  W. S. Koski,et al.  Physicochemical, Quantum Chemical, and Other Theoretical Techniques for the Understanding of the Mechanism of Action of CNS Agents: Psychoactive Drugs, Narcotics, and Narcotic Antagonists and Anesthetics , 1975 .

[11]  C. Hansch,et al.  The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics. , 1968, Journal of medicinal chemistry.

[12]  D. Ortwine,et al.  Substituted 2-benzothiazolamines as sodium flux inhibitors: quantitative structure-activity relationships and anticonvulsant activity. , 1994, Journal of pharmaceutical sciences.

[13]  H. Hara,et al.  Novel 4-substituted 2-piperazinylquinazolines as potent anticonvulsive and antihypoxic agents. , 1990, Chemical & pharmaceutical bulletin.

[14]  G. Webb,et al.  Electronic factors in the structure-activity relationship of some 1,4-benzodiazepin-2-ones. , 1977, Journal of medicinal chemistry.

[15]  A. Verloop,et al.  Development and Application of New Steric Substituent Parameters in Drug Design , 1976 .

[16]  W. Klunk,et al.  Comparison of epileptogenic properties of unsubstituted and beta-alkyl-substituted gamma-butyrolactones. , 1982, Molecular pharmacology.

[17]  A. Leo,et al.  Substituent constants for correlation analysis in chemistry and biology , 1979 .

[18]  C. R. Clark,et al.  Anticonvulsant activity of some 4-aminobenzamides. , 1984, Journal of medicinal chemistry.

[19]  H. Hara,et al.  Novel 4-phenoxy-2-(1-piperazinyl)quinazolines as potent anticonvulsive and antihypoxic agents. , 1990, Chemical & pharmaceutical bulletin.

[20]  J. Ferrendelli,et al.  Convulsant and anti-convulsant gammabutyrolactones bind at the picrotoxinin/T-butylbicyclophosphorothionate (TBPS) receptor. , 1985, Biochemical pharmacology.

[21]  J. Ferrendelli,et al.  Alpha-spirocyclopentyl- and alpha-spirocyclopropyl-gamma-butyrolactones: conformationally constrained derivatives of anticonvulsant and convulsant alpha,alpha-disubstituted gamma-butyrolactones. , 1994, Journal of medicinal chemistry.

[22]  H. Keasling,et al.  The relationship between structure and anticonvulsant activity in a series of benzenesulfonamides. , 1965, Journal of medicinal chemistry.

[23]  Y. Takahata,et al.  Quantitative Structure-Activity Relationships for 1,4-Dihydropyridine Calcium Channel Antagonists (Nifedipine Analogues): A Quantum ChemicalKlassical Approach , 1994 .

[24]  J. Yamada,et al.  A quantitative structure-activity study of anticonvulsant benzyl N,N-dimethylcarbamates. , 1982, Chemical & pharmaceutical bulletin.

[25]  C. Hansch Quantitative approach to biochemical structure-activity relationships , 1969 .

[26]  A. Soloway,et al.  Penetration of brain and brain tumor by aromatic compounds as a function of molecular substituents. , 1960, The Journal of pharmacology and experimental therapeutics.

[27]  Corwin Hansch,et al.  A survey of Hammett substituent constants and resonance and field parameters , 1991 .

[28]  C. Hansch,et al.  QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS OF THE BENZODIAZEPINES. A REVIEW AND REEVALUATION , 1994 .

[29]  H. Blaschko Inhibition in the nervous system and gamma-aminobutyric acid: (E. Roberts: Editor) Pergamon Press, Ltd., Oxford, 1960, 600 pp, 100s. , 1961 .

[30]  C. Hansch,et al.  Lipophilic character and biological activity of drugs. II. The parabolic case. , 1973, Journal of pharmaceutical sciences.

[31]  S. P. Gupta,et al.  QSAR studies on drugs acting at the central nervous system , 1989 .

[32]  E. Lien Structure-activity correlations for anticonvulsant drugs. , 1970, Journal of medicinal chemistry.

[33]  C. Hansch,et al.  Quantitative structure-activity relationships of cytochrome P-450. , 1993, Drug metabolism reviews.

[34]  E. Lien,et al.  Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants. , 1979, Journal of pharmaceutical sciences.

[35]  G. Glaser,et al.  Antiepileptic drugs : mechanisms of action , 1980 .

[36]  G. L. Tong,et al.  Structural requirements for centrally acting drugs. I. , 1973, Journal of pharmaceutical sciences.